nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB1—periodontitis	0.973	1	CbGaD
Nadolol—ADRB3—Adrenoceptors—ADRB1—periodontitis	0.00227	0.139	CbGpPWpGaD
Nadolol—Pirbuterol—ADRB1—periodontitis	0.00205	0.204	CrCbGaD
Nadolol—Levobunolol—ADRB1—periodontitis	0.00183	0.181	CrCbGaD
Nadolol—Carteolol—ADRB1—periodontitis	0.00155	0.154	CrCbGaD
Nadolol—Bupranolol—ADRB1—periodontitis	0.00132	0.131	CrCbGaD
Nadolol—ADRB2—Adrenoceptors—ADRB1—periodontitis	0.00132	0.0807	CbGpPWpGaD
Nadolol—Salbutamol—ADRB1—periodontitis	0.00124	0.123	CrCbGaD
Nadolol—Penbutolol—ADRB1—periodontitis	0.00121	0.12	CrCbGaD
Nadolol—Pindolol—ADRB1—periodontitis	0.000871	0.0865	CrCbGaD
Nadolol—ADRB3—Monoamine GPCRs—ADRB1—periodontitis	0.000804	0.0492	CbGpPWpGaD
Nadolol—ADRB3—Amine ligand-binding receptors—ADRB1—periodontitis	0.000676	0.0413	CbGpPWpGaD
Nadolol—ADRB2—Monoamine GPCRs—ADRB1—periodontitis	0.000467	0.0286	CbGpPWpGaD
Nadolol—ADRB3—G alpha (s) signalling events—VIP—periodontitis	0.000404	0.0247	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—ADRB1—periodontitis	0.000392	0.024	CbGpPWpGaD
Nadolol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00031	0.019	CbGpPWpGaD
Nadolol—ADRB3—G alpha (s) signalling events—ADRB1—periodontitis	0.000279	0.0171	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—CXCR2—periodontitis	0.000268	0.0164	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000266	0.0163	CbGpPWpGaD
Nadolol—ADRB2—Arf6 signaling events—MET—periodontitis	0.000251	0.0154	CbGpPWpGaD
Nadolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.000241	0.0147	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—VIP—periodontitis	0.00024	0.0147	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—VIP—periodontitis	0.000235	0.0143	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL3—periodontitis	0.000203	0.0124	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.0002	0.0123	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000178	0.0109	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000172	0.0105	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—ADRB1—periodontitis	0.000162	0.0099	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000158	0.00967	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000156	0.00953	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.000155	0.00949	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000155	0.00946	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00015	0.00919	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL13—periodontitis	0.000141	0.00863	CbGpPWpGaD
Nadolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00014	0.00855	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000133	0.00817	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000133	0.00813	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCR2—periodontitis	0.000131	0.008	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL17A—periodontitis	0.00013	0.00795	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL3—periodontitis	0.00012	0.00737	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000119	0.00727	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL3—periodontitis	0.000118	0.0072	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000116	0.00712	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL3—periodontitis	0.000115	0.00701	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL3—periodontitis	0.000104	0.00637	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000102	0.00623	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCR2—periodontitis	0.000102	0.00622	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—ADRB1—periodontitis	0.000101	0.00619	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	9.97e-05	0.0061	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	9.25e-05	0.00566	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	9.05e-05	0.00553	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	9.01e-05	0.00551	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL1A—periodontitis	8.88e-05	0.00543	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL10—periodontitis	8.83e-05	0.0054	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL4—periodontitis	8.59e-05	0.00525	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—VIP—periodontitis	8.29e-05	0.00507	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	7.92e-05	0.00485	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—periodontitis	7.82e-05	0.00478	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCR2—periodontitis	7.76e-05	0.00475	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	7.75e-05	0.00474	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	7.72e-05	0.00472	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCR2—periodontitis	7.59e-05	0.00464	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—VIP—periodontitis	7.53e-05	0.0046	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCR2—periodontitis	7.39e-05	0.00452	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL3—periodontitis	6.8e-05	0.00416	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCR2—periodontitis	6.71e-05	0.0041	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL3—periodontitis	6.66e-05	0.00407	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	6.58e-05	0.00402	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL3—periodontitis	6.18e-05	0.00378	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL3—periodontitis	6.15e-05	0.00376	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL3—periodontitis	6.04e-05	0.0037	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCR2—periodontitis	6.03e-05	0.00369	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCR2—periodontitis	5.9e-05	0.00361	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—ADRB1—periodontitis	5.88e-05	0.00359	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCR2—periodontitis	5.74e-05	0.00351	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—ADRB1—periodontitis	5.72e-05	0.0035	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCR2—periodontitis	5.22e-05	0.00319	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.2e-05	0.00318	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—ADRB1—periodontitis	5.19e-05	0.00318	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IFNG—periodontitis	5.19e-05	0.00318	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL2—periodontitis	5.01e-05	0.00306	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	4.98e-05	0.00305	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—VIP—periodontitis	4.92e-05	0.00301	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CXCL8—periodontitis	4.83e-05	0.00295	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—VIP—periodontitis	4.81e-05	0.00294	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL1B—periodontitis	4.63e-05	0.00283	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—VIP—periodontitis	4.47e-05	0.00273	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VIP—periodontitis	4.45e-05	0.00272	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCR2—periodontitis	4.38e-05	0.00268	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—VIP—periodontitis	4.37e-05	0.00267	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCR2—periodontitis	4.29e-05	0.00262	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCR2—periodontitis	3.98e-05	0.00244	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCR2—periodontitis	3.96e-05	0.00242	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL8—periodontitis	3.96e-05	0.00242	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—MMP3—periodontitis	3.95e-05	0.00242	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	3.9e-05	0.00239	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCR2—periodontitis	3.89e-05	0.00238	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	3.82e-05	0.00234	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL3—periodontitis	3.65e-05	0.00223	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TGFB1—periodontitis	3.6e-05	0.0022	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL3—periodontitis	3.57e-05	0.00218	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR2—periodontitis	3.41e-05	0.00209	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—periodontitis	3.36e-05	0.00206	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR2—periodontitis	3.34e-05	0.00204	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—ADRB1—periodontitis	3.32e-05	0.00203	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR2—periodontitis	3.1e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.09e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR2—periodontitis	3.08e-05	0.00189	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRB1—periodontitis	3.07e-05	0.00188	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR2—periodontitis	3.03e-05	0.00185	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.02e-05	0.00185	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—ADRB1—periodontitis	3.02e-05	0.00184	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC52A3—periodontitis	2.99e-05	0.00183	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL2—periodontitis	2.97e-05	0.00182	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL2—periodontitis	2.91e-05	0.00178	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	2.72e-05	0.00167	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VIP—periodontitis	2.64e-05	0.00161	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VIP—periodontitis	2.58e-05	0.00158	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL2—periodontitis	2.57e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NTRK1—periodontitis	2.51e-05	0.00154	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	2.46e-05	0.0015	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCR2—periodontitis	2.35e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL8—periodontitis	2.35e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—MMP3—periodontitis	2.35e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP3—periodontitis	2.34e-05	0.00143	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCR2—periodontitis	2.3e-05	0.00141	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL8—periodontitis	2.3e-05	0.00141	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—MMP3—periodontitis	2.3e-05	0.0014	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL8—periodontitis	2.24e-05	0.00137	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL8—periodontitis	2.03e-05	0.00124	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR2—periodontitis	1.83e-05	0.00112	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR2—periodontitis	1.79e-05	0.00109	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADRB1—periodontitis	1.78e-05	0.00109	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	1.78e-05	0.00109	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ACP5—periodontitis	1.76e-05	0.00108	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.66e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL2—periodontitis	1.53e-05	0.000933	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—periodontitis	1.52e-05	0.000929	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1.5e-05	0.000918	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—periodontitis	1.49e-05	0.000913	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTRK1—periodontitis	1.49e-05	0.000912	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTRK1—periodontitis	1.46e-05	0.000892	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP3—periodontitis	1.39e-05	0.000848	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FGF2—periodontitis	1.37e-05	0.00084	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP3—periodontitis	1.36e-05	0.00083	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	1.33e-05	0.000813	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	1.3e-05	0.000795	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL8—periodontitis	1.21e-05	0.000738	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL8—periodontitis	1.2e-05	0.000734	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL8—periodontitis	1.18e-05	0.000722	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—periodontitis	1.14e-05	0.000698	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—periodontitis	1.09e-05	0.000664	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GGT1—periodontitis	9.82e-06	0.000601	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—periodontitis	9.01e-06	0.000551	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—periodontitis	8.95e-06	0.000548	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—periodontitis	8.82e-06	0.000539	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGF2—periodontitis	8.15e-06	0.000498	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGF2—periodontitis	7.97e-06	0.000487	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL8—periodontitis	7.13e-06	0.000436	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARA—periodontitis	7.03e-06	0.00043	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL8—periodontitis	6.97e-06	0.000426	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—periodontitis	6.78e-06	0.000415	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—periodontitis	6.74e-06	0.000413	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—periodontitis	6.63e-06	0.000406	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—periodontitis	6.45e-06	0.000394	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—periodontitis	6.3e-06	0.000386	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—periodontitis	5.31e-06	0.000325	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—periodontitis	5.2e-06	0.000318	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—periodontitis	4.57e-06	0.000279	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—periodontitis	4e-06	0.000245	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—periodontitis	3.92e-06	0.00024	CbGpPWpGaD
